Regeneron Pharmaceuticals... (REGN)
572.76
-37.88 (-6.20%)
At close: Apr 04, 2025, 3:59 PM
573.45
0.12%
After-hours: Apr 04, 2025, 04:46 PM EDT
Regeneron Pharmaceuticals Revenue
Regeneron Pharmaceuticals reported an annual revenue of $14.2B, reflecting a 8.27% growth. For the quarter ending December 31, 2024, Regeneron Pharmaceuticals generated $3.79B in revenue.
Revenue (ttm)
$14.2B
Revenue Growth
8.27%
Price / Sales Ratio
5.41
Revenue / Employee
$940.16K
Employees
15,106
Market Cap
61.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 14.2B | +8.27% |
| Dec 31, 2023 | 13.12B | +7.76% |
| Dec 31, 2022 | 12.17B | -24.26% |
| Dec 31, 2021 | 16.07B | +89.14% |
| Dec 31, 2020 | 8.5B | n/a |